cefepime hydrochloride
Drug ingredientThis chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.
Where It Comes From
14 FDA-registered drug labelers
ACS Dobfar S.p.A
Antibioticos do Brasil Ltda
Apotex Corp.
B. Braun Medical Inc.
Baxter Healthcare Company
Fresenius Kabi USA, LLC
Hikma Pharmaceuticals USA Inc.
Hospira, Inc.
Orchid Pharma Ltd
Qilu Antibiotics Pharmaceutical Co., Ltd.
Qilu Pharmaceutical Co., Ltd.
Sagent Pharmaceuticals
SAMSON MEDICAL TECHNOLOGIES LLC
WG Critical Care, LLC
Why It Matters
Sectors
Health
Downstream Uses
Appears in 3 drug and cosmetic product listings (FDA).
- •Cefepime
- •Cefepime Hydrochloride
- •Cefepime Hydrochloride AND Dextrose
FDA Shortage Status
Whether any manufacturer currently reports this drug as in shortage on the FDA Drug Shortages database. "Active Shortage" means at least one presentation has status "current."
No Shortage
Shortage History
Each row is a separate manufacturer's FDA shortage filing — not a timeline for the drug as a whole. Multiple "current" entries are normal: each manufacturer/NDC files independently. Status reflects the manufacturer's report; reason describes their supply situation (Available, Unavailable, or to be discontinued).
to be discontinued
Cefepime Hydrochloride Injection
02/10/2026Chemical Identity
CAS123171-59-5
PubChem CID9571075
DTXSIDDTXSID7045603
FormulaC19H28Cl2N6O6S2
Mol. Weight571.5 g/mol
SMILESC[N+]1(CCCC1)CC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)O.O.Cl.[Cl-]
Data Sources
95710752026-04-07
https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/cefepime hydrochloride/cids/JSON
Archive: data/sources/pubchem_name/cefepime hydrochloride.json
CAS 123171-59-52026-04-25
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json
CAS 123171-59-52026-06-13
https://api.fda.gov/drug/shortages.json
Archive: data/sources/fda/shortages/shortages.json